X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22057) 22057
Book Review (3825) 3825
Publication (1151) 1151
Newsletter (1132) 1132
Conference Proceeding (284) 284
Book Chapter (93) 93
Newspaper Article (60) 60
Magazine Article (54) 54
Dissertation (10) 10
Trade Publication Article (10) 10
Web Resource (10) 10
Book / eBook (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infliximab (20495) 20495
humans (14242) 14242
index medicus (13994) 13994
female (8037) 8037
male (7841) 7841
antibodies, monoclonal - therapeutic use (6304) 6304
adult (6303) 6303
middle aged (5776) 5776
tumor necrosis factor-alpha - antagonists & inhibitors (5070) 5070
gastroenterology & hepatology (4562) 4562
etanercept (4550) 4550
treatment outcome (4387) 4387
rheumatology (4211) 4211
adalimumab (4192) 4192
therapy (3448) 3448
crohn's disease (3154) 3154
rheumatoid arthritis (3129) 3129
aged (2969) 2969
antirheumatic agents - therapeutic use (2931) 2931
arthritis, rheumatoid - drug therapy (2773) 2773
crohns-disease (2733) 2733
rheumatoid-arthritis (2657) 2657
antibodies, monoclonal - adverse effects (2654) 2654
inflammatory-bowel-disease (2640) 2640
crohn disease - drug therapy (2604) 2604
care and treatment (2326) 2326
ulcerative colitis (2296) 2296
inflammatory bowel disease (2167) 2167
monoclonal antibodies (2090) 2090
methotrexate (2013) 2013
efficacy (1981) 1981
drug therapy (1955) 1955
adolescent (1952) 1952
double-blind (1776) 1776
abridged index medicus (1770) 1770
young adult (1738) 1738
retrospective studies (1719) 1719
severity of illness index (1708) 1708
research (1700) 1700
dermatology (1628) 1628
anti-inflammatory agents - therapeutic use (1612) 1612
psoriasis (1598) 1598
arthritis (1596) 1596
immunosuppressive agents - therapeutic use (1583) 1583
immunoglobulin g - therapeutic use (1558) 1558
pharmacology & pharmacy (1550) 1550
receptors, tumor necrosis factor - therapeutic use (1549) 1549
antibodies, monoclonal - administration & dosage (1537) 1537
risk factors (1517) 1517
tumor necrosis factor (1462) 1462
necrosis-factor-alpha (1441) 1441
tumor necrosis factor-α (1434) 1434
gastrointestinal agents - therapeutic use (1392) 1392
medicine & public health (1390) 1390
patients (1379) 1379
safety (1353) 1353
drug therapy, combination (1337) 1337
antirheumatic agents - adverse effects (1307) 1307
disease (1304) 1304
infliximab - therapeutic use (1257) 1257
follow-up studies (1215) 1215
ulcerative-colitis (1205) 1205
antibodies, monoclonal, humanized (1190) 1190
colitis, ulcerative - drug therapy (1177) 1177
immunology (1167) 1167
medical research (1167) 1167
child (1152) 1152
medicine, general & internal (1133) 1133
tumor-necrosis-factor (1122) 1122
trial (1091) 1091
inflammation (1064) 1064
medicine, experimental (1060) 1060
analysis (1044) 1044
dosage and administration (1042) 1042
remission (1016) 1016
prospective studies (1014) 1014
time factors (1008) 1008
animals (1001) 1001
inflammatory bowel diseases - drug therapy (996) 996
surgery (995) 995
management (993) 993
tumor necrosis factor-tnf (990) 990
tumor necrosis factor-alpha - immunology (982) 982
azathioprine (980) 980
health aspects (970) 970
tnf-alpha (963) 963
ankylosing spondylitis (948) 948
remission induction (931) 931
psoriasis - drug therapy (921) 921
diagnosis (912) 912
antibodies, monoclonal, humanized - therapeutic use (889) 889
methotrexate - therapeutic use (887) 887
monoclonal-antibody (874) 874
rheumatoid factor (831) 831
inflammatory bowel diseases (816) 816
children (807) 807
complications and side effects (803) 803
antibodies (795) 795
placebo-controlled trial (793) 793
crohn disease - complications (784) 784
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21213) 21213
Spanish (447) 447
French (416) 416
German (400) 400
Japanese (289) 289
Korean (148) 148
Russian (103) 103
Portuguese (77) 77
Italian (75) 75
Polish (75) 75
Hungarian (40) 40
Danish (38) 38
Czech (36) 36
Turkish (31) 31
Dutch (27) 27
Chinese (25) 25
Croatian (14) 14
Slovak (12) 12
Hebrew (9) 9
Swedish (6) 6
Finnish (5) 5
Norwegian (5) 5
Icelandic (3) 3
Persian (2) 2
Romanian (2) 2
Serbian (2) 2
Greek (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, p. A163
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2017.10.116 Il... 
Infliximab
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, p. A164
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2017.10.117... 
Infliximab
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2016, Volume 37, p. A266-A267
L'infliximab est un anticorps monoclonal chimerique (humain-murin) qui a montre des effets therapeutiques spectaculaires chez les patients atteints de... 
Infliximab
Journal Article
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2014, Volume 35, p. A113-A114
Les uveites chroniques non infectieuses representent un defi therapeutique pour l'interniste. Le traitement repose sur la corticotherapie et les... 
Infliximab
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 12/2015, Volume 82, Issue 6, p. 411
L'hidrosadenite suppuree (HS) severe, traitee par infliximab, peut etre associee a differentes formes de manifestation articulaire inflammatoire dont le... 
Infliximab
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2015, Volume 36, p. A93
Les anti-TNF alpha sont rentres dans l'arsenal therapeutique des uveites inflammatoires severes. Cependant, il existe tres peu de donnees comparant... 
Infliximab
Journal Article
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 04/2017, Volume 64, Issue 4, pp. 580 - 585
Journal Article
Gut, ISSN 0017-5749, 10/2015, Volume 64, Issue 10, pp. 1539 - 1545
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 12/2014, Volume 81, Issue 6, p. 483
Comparer les taux de retention de l'adalimumab, de l'etanercept et de l'infliximab en tant que biotherapie de 1.sup.re intention dans la polyarthrite... 
Infliximab
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2017, Volume 76, Issue 1, pp. 58 - 64
Journal Article
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 01/2016, Volume 18, Issue 1, pp. 25 - 25
Background: CT-P13 (Remsima (R), Inflectra (R)) is a biosimilar of the infliximab reference product (RP; Remicade (R)) and is approved in Europe and elsewhere,... 
Immunogenicity | Infliximab | Clinical trial | Efficacy | ASAS | Safety | CT-P13 | Pharmacokinetics | Ankylosing spondylitis | Biosimilar | MULTICENTER | INNOVATOR INFLIXIMAB | ACTIVE RHEUMATOID-ARTHRITIS | METHOTREXATE | MONOCLONAL-ANTIBODY | RHEUMATOLOGY | 2010 UPDATE | SPONDYLOARTHRITIS | RECOMMENDATIONS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Infliximab - therapeutic use | Infliximab - pharmacokinetics | Young Adult | Infliximab - adverse effects | Antirheumatic Agents - adverse effects | Biosimilar Pharmaceuticals - pharmacokinetics | Adult | Female | Neutropenia - chemically induced | Antirheumatic Agents - therapeutic use | Biosimilar Pharmaceuticals - therapeutic use | Double-Blind Method | Spondylitis, Ankylosing - drug therapy | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Spondylitis, Ankylosing - metabolism | Biosimilar Pharmaceuticals - adverse effects | Self Report - standards | Spondylitis, Ankylosing - diagnosis | Internationality | Adolescent | Antirheumatic Agents - pharmacokinetics | Aged | Chemical and Drug Induced Liver Injury | Longitudinal Studies | Complications and side effects | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Dosage and administration | Research | Drug therapy | Methods | Index Medicus
Journal Article
Journal Article